Patients who have undergone major surgery or trauma within  days prior to the first dose of investigational product and/or present with any non-healing wound, fracture, or ulcer are NOT eligible for participation; procedures such as catheter placement not considered to be major surgery
Major surgery or trauma within  days prior to first dose of investigational product and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major surgery)
Patient has had major surgery or insufficient recovery from surgical-related trauma or wound healing within  days of study day 
Insufficient recovery from surgical-related trauma or wound healing
Patients who have had major surgery or have insufficient recovery from surgical-related trauma or wound healing within  days from study day 
Patients who are less than  weeks from surgery (except biopsies) or have insufficient recovery from surgical-related trauma or wound healing
Insufficient recovery from surgical-related trauma or wound healing
Subjects who are less than  days from surgery or have insufficient recovery from surgical-related trauma or wound healing.
Patients who are less than  weeks from surgery or have insufficient recovery from surgical-related trauma or wound healing
Major surgery or trauma within  days prior to first dose of investigational product and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement are not considered to be major surgery)
Patient has had major surgery or insufficient recovery from surgical-related trauma or wound healing within  days of study day 
Patients who are less than  weeks from CRS/HIPEC or have insufficient recovery from surgical-related trauma or wound healing as determined by the patients surgeon
Major surgery or trauma within  days prior to first dose of pazopanib and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major surgery)
Prior major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)
Major surgery or trauma within  days prior to first dose of pazopanib and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major surgery)
Insufficient recovery from surgical-related trauma or wound healing
Major surgery or trauma within  days prior to first dose of study treatment and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major surgery)
Prior major surgery or trauma within  days and/or presence of any non-healing wound, fracture or ulcer (procedures such as catheter placement not considered to be major)
Major surgery or trauma within  days prior to first dose of investigational product and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major surgery)
Patient must not have prior major surgery, trauma, presence of any non-healing wound, fracture, or ulcer within  days prior to first dose of study drug
Less than  weeks from surgery or insufficient recovery from surgical-related trauma or wound healing
Prior major surgery or trauma within  days prior to registration and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major); if the patient has a compression fracture secondary to tumor this should be treated and  days elapsed prior to entry on the protocol
Prior major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)
Major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer not related to cancer (procedures such as catheter placement not considered to be major)
Prior major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)
Prior major surgery or trauma within  days prior to first dose of pazopanib and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)
Prior major surgery (defined as requiring general anesthesia) or trauma within  days prior to first dose of study drug, and/or not recovered from effects of that surgery, and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major), or patients that may require surgery during the course of the study
EXPANSION COHORT ONLY: Prior major surgery (defined as requiring general anesthesia) or trauma within  days prior to first dose of study drug, and/or not recovered from effects of that surgery, and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major), or patients that may require surgery during the course of the study
Prior major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)
Prior major surgery or trauma within  days prior to the protocol-mandated -week drug holiday and/or presence of any non-healing wound, fracture, or ulcer.
Prior major surgery or trauma within  days prior to the first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer.
Prior major surgery or trauma within  days of the first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer
Major surgery or trauma within  days prior to first dose of investigational product and/or presence of any non-healing wound, fracture, or ulcer
Major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture or ulcer (catheter placement is not major surgery)
Patient must not have prior major surgery or trauma within  days prior to first dose of study drug and/or presence of any non-healing wound, fracture, or ulcer (procedures such as catheter placement not considered to be major)